GAF Healthcare
Specialty Overview

Best Hospitals for Fanconi Anemia Treatment in Dubai, UAE

3 bone marrow transplant hospitals in our UAE network are listed in Dubai, accredited by Hospital Certificates of Services, JCI, with 423 beds combined.

3
Hospitals Listed
1
City
4.5
Avg. Rating
2
Accreditation Types
The Short Answer

This page lists the bone marrow transplant hospitals in our directory offering Fanconi Anemia Treatment in Dubai, UAE, including Burjeel Hospital for Advanced Surgery Dubai, Kings College Hospital Dubai, Aster Hospital Dubai. Each listing links through to the hospital's full profile page.

Including:🇦🇪 Burjeel Hospital for Advanced Surgery Dubai🇦🇪 Kings College Hospital Dubai🇦🇪 Aster Hospital Dubai

Ask us about fanconi anemia treatment in Dubai, UAE

Share a few details and our care coordination team will get back to you with next steps.

Compare 3 accredited hospitals for Bone Marrow Transplant in Dubai, UAE

Burjeel Hospital for Advanced Surgery Dubai Featured
Starting from$18,000

🇦🇪 Burjeel Hospital for Advanced Surgery Dubai

Dubai, UAE 4.5 (1 reviews) 209 beds
Why consider this hospital?
4.5/5 rating from 1 reviewsAccredited by Hospital Certificates of Services209 beds
Specialties & Accreditation
OrthopedicsCardiac SciencesCosmetic SurgeryGastroenterologyGeneral SurgeryGynecology
Accredited by Hospital Certificates of Services
View full profile →

Patients considering fanconi anemia treatment can be cared for by Burjeel Hospital for Advanced Surgery Dubai's care team in Dubai, UAE, from initial consultation through recovery. Burjeel Hospital for Advanced Surgery Dubai, accredited by Hospital Certificates of Services, follows recognised patient-safety and quality-of-care standards when performing fanconi anemia treatment.

4.5/5
Rating
2014
Established
209
Beds
Dubai, UAE
Location
Enquire NowView Profile
Kings College Hospital Dubai
Starting from$18,000

🇦🇪 Kings College Hospital Dubai

Dubai, UAE 4.5 (1 reviews) 100 beds
Why consider this hospital?
4.5/5 rating from 1 reviewsAccredited by Hospital Certificates of Services100 beds
Specialties & Accreditation
Cardiac SciencesCosmetic SurgeryENTGastroenterologyGeneral SurgeryGynecology
Accredited by Hospital Certificates of Services
View full profile →

Patients considering fanconi anemia treatment can be cared for by Kings College Hospital Dubai's care team in Dubai, UAE, from initial consultation through recovery. Kings College Hospital Dubai, accredited by Hospital Certificates of Services, follows recognised patient-safety and quality-of-care standards when performing fanconi anemia treatment.

4.5/5
Rating
2014
Established
100
Beds
Dubai, UAE
Location
Enquire NowView Profile
Aster Hospital Dubai
Starting from$18,000

🇦🇪 Aster Hospital Dubai

Dubai, UAE 4.5 (1 reviews) 114 beds
Why consider this hospital?
4.5/5 rating from 1 reviewsAccredited by JCI114 beds
Specialties & Accreditation
BariatricCardiac SciencesCosmetic SurgeryENTGastroenterologyGeneral Surgery
Accredited by JCI
View full profile →

Patients considering fanconi anemia treatment can be cared for by Aster Hospital Dubai's care team in Dubai, UAE, from initial consultation through recovery. Aster Hospital Dubai, accredited by JCI, follows recognised patient-safety and quality-of-care standards when performing fanconi anemia treatment.

4.5/5
Rating
1987
Established
114
Beds
Dubai, UAE
Location
Enquire NowView Profile
Our Methodology

How we selected these hospitals

A hospital appears on this page when Bone Marrow Transplant is among its listed specialties and it is located in Dubai, UAE. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Fanconi Anemia Treatment in Dubai, UAE?

Choosing the right hospital for fanconi anemia treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include bone marrow transplant rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Fanconi Anemia Treatment

Fanconi Anaemia (FA) is a rare inherited bone marrow failure syndrome requiring curative intervention through allogeneic Hematopoietic Stem Cell Transplantation (HSCT) using Reduced-Intensity Conditioning (RIC) regimens, which significantly lower transplant-related toxicity for this genetically fragile patient population.

35–60 days (inpatient BMT unit stay, including pre-conditioning, transplant, and engraftment monitoring)
Hospital Stay
12–20 weeks (fit-to-fly clearance issued only after stable engraftment, immune reconstitution milestones, and infectious disease clearance by the transplant physician)
Total Stay in Country (Fit-to-Fly)
75–90% overall survival at 1 year (matched sibling donor); 60–75% with matched unrelated donor (MUD) in FA-specific RIC protocols
Success Rate

Clinical Overview

  • Fanconi Anaemia is an autosomal recessive (and occasionally X-linked) DNA repair disorder caused by biallelic pathogenic variants in one of at least 22 FANC genes (most commonly FANCA, FANCC, FANCG, and FANCD2), which encode proteins of the FA/BRCA DNA damage response pathway.
  • The cellular inability to repair interstrand DNA crosslinks leads to progressive bone marrow failure, presenting clinically as pancytopenia (severe anaemia, thrombocytopenia, and neutropenia), a markedly elevated risk of myelodysplastic syndrome (MDS), and acute myeloid leukaemia (AML).
  • Patients also carry a lifetime predisposition to solid tumours, particularly squamous cell carcinomas of the head, neck, and gynaecological tract, underscoring the urgency of curative intervention before clonal haematopoietic evolution occurs.
Full details →

Who is a Candidate?

  • Confirmed genetic diagnosis of Fanconi Anaemia: biallelic pathogenic FANC gene variants identified by next-generation sequencing (NGS) gene panel; FA confirmed by chromosomal breakage test using diepoxybutane (DEB) or mitomycin C (MMC) on peripheral blood lymphocytes (the gold-standard diagnostic assay)
  • Moderate-to-severe aplastic anaemia (MSAA/SAA): absolute neutrophil count (ANC) <1,000/µL, platelet count <50,000/µL, or transfusion dependence (>8 RBC units per year)
  • Absence of advanced MDS (IPSS-R intermediate or higher) or AML at time of transplant (active transformation is a relative contraindication requiring disease-specific cytoreduction first)
  • Age: Pediatric patients (1–18 years) carry the best outcomes; adult transplantation (18–40 years) is feasible at experienced centers; transplant is generally not offered beyond age 50 due to exponentially rising RIC toxicity
  • +2 more

Required Pre-Transplant Diagnostic Workup:

Full details →

Treatment Options & Approaches

  • **1.
  • Matched Sibling Donor (MSD) HSCT with FA-Specific RIC – Gold Standard** The preferred and most evidence-supported approach.
  • The Fludarabine-Cyclophosphamide (Flu/Cy) conditioning backbone uses Fludarabine 150 mg/m² (30 mg/m²/day × 5 days) combined with Cyclophosphamide at steeply reduced doses of 40 mg/kg total (compared to 120–200 mg/kg in non-FA myeloablative regimens), exploiting Fludarabine's profound T-cell immunosuppression to permit engraftment while cyclophosphamide provides additional myelosuppression at a tolerable DNA-damage burden.

Recovery

  • **Phase 1: Pre-Transplant Workup and Donor Search (Weeks 1–8 before admission)**

Risks to be aware of

  • Fanconi Anaemia HSCT with RIC carries significant procedural and post-procedural risks that are specific to and amplified by the underlying FA biology, and all prospective patients must receive thorough informed consent covering the following:
Full details →

Why GAF Healthcare

  • GAF Healthcare provides a comprehensive, fully coordinated non-medical support infrastructure designed specifically for international patients undergoing prolonged, complex treatments such as FA HSCT.
  • The following services are included or arranged for all patients:

Cost Range for Related Procedures

Bone Marrow Transplant (BMT)$18,000–$35,000
Get a personalised estimate with our cost calculator →

Common questions about Fanconi Anemia Treatment

What is the cost of Fanconi Anaemia Treatment (Curative BMT with Reduced-Intensity Conditioning) in India vs. UAE?
The total cost of Fanconi Anaemia HSCT with Reduced-Intensity Conditioning varies based on donor type (matched sibling, unrelated, or haploidentical), the length of the inpatient stay, complications encountered, and the specific hospital's package structure. In India, at NABH- and JCI-accredited transplant centers such as those in Delhi, Mumbai, Chennai, and Hyderabad, the all-inclusive estimated cost ranges from USD 25,000 to USD 55,000. This range covers pre-transplant HLA typing, conditioning chemotherapy (Fludarabine + Cyclophosphamide ± low-dose TBI), the stem cell infusion, 35–60 days of inpatient BMTU care, blood products, standard prophylactic medications, and post-engraftment outpatient monitoring through approximately Day +100. Unrelated donor transplants involving international registry search fees (NMDP/DKMS donor procurement costs of USD 10,000–25,000) are typically charged separately and can add significantly to the base estimate. In the UAE, at JCI- and DHA-accredited centers in Dubai and Abu Dhabi, the equivalent procedure is estimated at USD 60,000 to USD 120,000, reflecting premium infrastructure, higher nursing-to-patient ratios, and the higher operational cost environment. In both destinations, GAF Healthcare provides a fully itemized cost estimate based on the patient's specific clinical profile and donor situation before any financial commitment is made.
How long do I need to stay in the country before I am fit to fly home after FA transplant?
Fanconi Anaemia HSCT requires one of the longest mandatory in-country stays of any transplant indication. Patients should plan for a total stay of 12 to 20 weeks (approximately 3 to 5 months) from the date of hospital admission. The inpatient phase alone typically spans 35 to 60 days in the BMTU isolation room, covering the conditioning regimen, transplant day, engraftment, and initial post-engraftment stability. Following discharge from inpatient care, patients must remain within 30–60 minutes of the transplant center for intensive outpatient monitoring (clinic visits 2–3 times per week initially) through at least Day +100 post-transplant. Fit-to-fly clearance is issued by the transplant physician only when all of the following criteria are simultaneously met: sustained donor chimerism ≥95% on at least 2 consecutive chimerism studies; absolute neutrophil count ≥1,000/µL without growth factor support; no active graft-versus-host disease requiring escalation; no active viral reactivation (CMV, EBV, adenovirus) detectable by PCR; confirmed ability to absorb oral immunosuppressants reliably; and a confirmed follow-up plan with a qualified haematologist in the patient's home country. Patients who experience complications such as GvHD, infection, or delayed engraftment may require a stay of 5–6 months or longer. The attending transplant physician's clinical judgment is the sole determinant of safe travel clearance; GAF Healthcare does not set or override this medical decision.
What is the success rate for Fanconi Anaemia BMT with Reduced-Intensity Conditioning?
Success rates for FA HSCT depend primarily on the donor type, the patient's disease stage at the time of transplant, patient age, and the volume and FA-specific expertise of the transplant center. For matched sibling donor (MSD) transplants using the Fludarabine-Cyclophosphamide (Flu/Cy) RIC protocol, published data from high-volume international centers report 1-year overall survival (OS) rates of 85–92% in pediatric patients and 75–85% in adults, with long-term 5-year OS of 70–85%. These outcomes are markedly better when transplantation is performed before the development of MDS, AML, or clonal cytogenetic abnormalities. For matched unrelated donor (MUD) transplants (8/8 HLA allele match) using Flu/Cy/TBI RIC, 1-year OS rates range from 60–75%, reflecting the higher GvHD risk and delayed engraftment associated with unrelated donors. Haploidentical donor transplants using the PTCy platform report OS of 55–70% in the most experienced FA-specific centers. Graft failure occurs in 5–10% of MSD cases and up to 15% of MUD/haploidentical cases, representing the most immediately life-threatening complication. Overall transplant-related mortality (TRM) at 1 year ranges from 5–10% (MSD, experienced center) to 15–30% (MUD or haploidentical). The centers recommended by GAF Healthcare are specifically selected based on their documented FA transplant volume, published outcomes, and membership in the Fanconi Anemia Research Fund (FARF) clinical network or equivalent FA-specialized consortia, which is associated with superior outcomes compared to general BMT programs with limited FA experience.

Related pages

How GAF Healthcare Assists in Choosing the Best Hospital for Fanconi Anemia Treatment in Dubai, UAE

Discover the Top Hospitals for Fanconi Anemia Treatment in Dubai, UAE

This page lists 3 accredited bone marrow transplant hospitals in Dubai, UAE, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about fanconi anemia treatment in Dubai, UAE

How many bone marrow transplant hospitals are listed in Dubai, UAE?
3 hospitals in our Dubai, UAE directory are currently listed for bone marrow transplant including Fanconi Anemia Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Bone Marrow Transplant is among its listed specialties and it is located in Dubai, UAE. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in UAE?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there bone marrow transplant hospitals for this in other UAE cities?
See the "Hospitals in other cities" links on this page for the full UAE list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including Hospital Certificates of Services, JCI — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for fanconi anemia treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about fanconi anemia treatment in Dubai, UAE.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for fanconi anemia treatment in Dubai, UAE.

Contact us to report an inaccuracy on this page.

WhatsApp Us